| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 24 |
| 1 | METHOTREXATE | 21 |
| 2 | METOPROLOL | 17 |
| 3 | METOPROLOL TARTRATE | 17 |
| 4 | METOPROLOL TARTRATE INJECTION | 17 |
| 5 | TORSEMIDE | 17 |
| 6 | VALSARTAN | 17 |
| 7 | VALSARTAN ORAL | 17 |
| 8 | ACETAMINOPHEN | 16 |
| 9 | ADALIMUMAB | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VERAPAMIL HYDROCHLORIDE | 12 | 0.0028 |
| 1 | DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS | 1 | 0.0026 |
| 2 | ESCHERICHIA COLI | 1 | 0.0025 |
| 3 | CAPTOPRIL | 13 | 0.0014 |
| 4 | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | 1 | 0.0012 |
| 5 | FELODIPINE | 13 | 0.0011 |
| 6 | PRAZOSIN HYDROCHLORIDE | 1 | 0.0007 |
| 7 | CEFACLOR | 1 | 0.0006 |
| 8 | MISOPROSTOL | 6 | 0.0006 |
| 9 | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | 2 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Semifluorinated Alkane [EPC] | 1 | 0.0004 |
| 1 | Prostaglandin E1 Analog [EPC] | 6 | 0.0004 |
| 2 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 3 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 4 | Thyroid Hormone Synthesis Inhibitor [EPC] | 2 | 0.0002 |
| 5 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 6 | Allylamine Antifungal [EPC] | 1 | 0.0001 |
| 7 | Antirheumatic Agent [EPC] | 12 | 0.0001 |
| 8 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 9 | Leukotriene Receptor Antagonist [EPC] | 3 | 0.0001 |